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Abstract Endoplasmic reticulum (ER) stress contributes
to beta cell death in type 2 diabetes (T2DM). ER stress is
characterized by increased level of ER stress markers such
as C/EBP homologous protein (CHOP). Activation of
CHOP leads to its translocation into the nucleus, where it
induces cell death. We previously reported nuclear CHOP
in pancreatic sections from T2DM, but not T1DM, and in
human islet amyloid polypeptide (IAPP) transgenic rodent
pancreatic sections. These studies underscore the impor-
tance of studying nuclear CHOP. We have observed
inconsistency in the detection of CHOP antibodies reported
in the literature and also in our own experiments. To
investigate the speciﬁcity of CHOP antibodies, we ﬁrst
induced ER stress by tunicamycin in rat insulinoma (INS)
cells and prepared nuclear and cytoplasmic fractions. Then
we examined CHOP expression by Western blotting and
immunocytochemistry using seven commercially available
CHOP antibodies in INS cells and human IAPP (h-IAPP)
transgenic rodent pancreatic tissue. These studies show that
three commercially available CHOP antibodies out of
seven tested were non-speciﬁc. In conclusion, we give
recommendations for CHOP antibody selection and meth-
ods to verify CHOP antibody speciﬁcity. Also, we propose
that the authors report the catalog and lot numbers of the
CHOP antibodies used.
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Introduction
Endoplasmic reticulum (ER) stress is an important pathway
of the increased apoptosis in beta cells in type 2 diabetes
(T2DM) [1–4] and neurons in neurodegenerative diseases.
As such, it is a fast moving ﬁeld with more than 1,000
citations in the last 2 years. One of the most commonly
used indicators of ER stress is the increased expression and
nuclear translocation of the transcription factor C/EBP
homologous protein (CHOP) [5].
T2DM and neurodegenerative diseases share the char-
acteristic of pathological formation of toxic oligomers of
locally expressed amyloidogenic proteins, Alzheimers’
beta protein in Alzheimers disease, synuclein in Parkin-
son’s disease, and islet amyloid polypeptide (IAPP) in
T2DM. IAPP is a 27-kDa protein that is co-expressed and
co-secreted with insulin. Human IAPP (h-IAPP) but not
rodent IAPP (r-IAPP) is amyloidogenic. High expression
rates of h-IAPP but not r-IAPP induces ER stress and
apoptosis in rat insulinoma (INS) cells due to ER stress.
Likewise high transgenic expression of h-IAPP but not
r-IAPP in rodent beta cells induces apoptosis and ER stress
[2, 6].
In studies of h-IAPP-induced beta cell apoptosis, we
noted that commercially available antibodies for detection
of CHOP by Western blotting and immunohistochemistry
include several that are completely non-speciﬁc and others
that vary from speciﬁc to non-speciﬁc from lot-to-lot.
Given the large number of high proﬁle papers in the ER
stress ﬁeld at present, we document this technical issue
here for the beneﬁt of other investigators.
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Cell Culture, Viral Transduction, and Tunicamycin
Treatment
Rat insulinoma INS 832/13 were cultured as described
previously [6]. INS cells were plated on a 60-mm tissue
culture dish at a density of 3.0 9 10
6 cells/dish and cul-
tured overnight. Cells were transduced with adenoviruses
expressing human or rat preproIAPP-EGFP (h-IAPP or
r-IAPP, respectively) or green ﬂuorescein protein (GFP) at
multiplicity of infection (MOI) = 100 [2]. Tunicamycin
(Sigma) was added to cells at 0.5 lg/ml 24 h after trans-
duction. Eighteen hours later, cells were washed with PBS
and collected by scraping in PBS. For a positive control,
cells were treated with 1 or 5 lg/ml tunicamycin or nothing
for 6 h. For immunocytochemistry, INS cells were grown
in Permanox Lab-Tek 8-well chamber slides (Nunc,
Rochester, NY) and transduced with h-IAPP for 48 h.
Western Blot Analysis
Nuclear and cytoplasmic fractions were extracted using the
kit from Pierce according to the manufacturer’s instruc-
tions (Pierce, Rockford, IL). Protein concentrations were
determined using the BCA protein assay (Bio-Rad, Her-
cules, CA). About 10 or 5 lg of cytoplasmic or nuclear
protein, respectively, was separated on 4–12% Bis–Tris
NuPAGE gels and blotted onto a PVDF membrane (Pall,
Ann Arbor, MI). Membranes were probed with rabbit
polyclonal or mouse monoclonal antibodies against CHOP
(ab11419, Abcam, Cambridge, MA; sc-7351, sc-575 and
sc-793, Santa Cruz, CA; G6916, Sigma), GAPDH, or PARP
(Cell Signaling, Beverly, MA) as primary antibodies.
Horseradish peroxidase-conjugated secondary antibodies
(1:3,000) were from Zymed. Proteins were visualized using
enhanced chemiluminescence (ECL, Millipore). CHOP was
detected ﬁrst, and then membranes were reused after
stripping the primary antibody using Pierce stripping buffer.
In order to get a good CHOP signal in a Western blot from
rodent islet total protein lysates, we have combined one
rabbit polyclonal and one mouse monoclonal CHOP anti-
body and performed detection using a mixture of rabbit and
mouse secondary antibodies.
Transgenic Model and Immunocytochemistry
Human IAPP transgenic rat and mice were maintained and
housed in accordance with Institutional Animal Care and
Use Committee guidelines at UCLA. Pancreatic sections
were prepared from 4% paraformaldehyde (EMS, Hatﬁeld,
PA) ﬁxed tissue and immunostained as previously described
[2, 6]. For CHOP detection in INS cells, h-IAPP expressing
INS cells were ﬁxed with 4% paraformaldehyde for 20 min
at room temperature and stained for CHOP antibodies (see
above). Slides were viewed under the ﬂuorescent micro-
scope DM6000 (Leica, Germany) using 209 objective.
Results
Tunicamycin-Induced CHOP Nuclear Translocation
in INS Cells was Detected by Four Out of Seven CHOP
Antibodies Tested
In an attempt to identify speciﬁc CHOP antibodies for
Western blotting, we used cell fractionation in tunicamy-
cin-treated INS cells. As shown in Fig. 1a, CHOP was
detected in the nuclear fraction with four out of seven
CHOP antibodies tested. This experiment demonstrated
that nuclear fractionation should be used to test the speci-
ﬁcity of CHOP antibodies.
Nuclear CHOP Expression in Pancreatic Tissue
was Detected by Three Out of Seven Antibodies Tested
We have previously shown nuclear CHOP in pancreatic
sections of type 2 diabetic humans and h-IAPP transgenic
rodents [2, 6]. As shown in Fig. 1b, not all CHOP anti-
bodies detected nuclear CHOP. About 8.5 ± 1.9% h-IAPP
expressing INS cells were nuclear CHOP-positive using
mouse monoclonal or rabbit polyclonal antibody. In mouse
tissue, nuclear CHOP was detected only using rabbit anti-
body and the proportion of nuclear CHOP in beta cells was
0.8 ± 0.1%. None of the antibodies tested detected CHOP
when frozen tissue sections were used.
Conclusions
We report that three out of seven commercially available
CHOP antibodies tested gave false results by Western
blotting and immunocytochemistry for detection of CHOP.
Investigators using CHOP protein expression to establish
the presence or absence of ER stress are strongly advised to
establish the speciﬁcity of antibodies used, especially since
we even observed a lot-to-lot variance in speciﬁcity from
the same commercial source.
Weadvisethatpositivecontrolexperimentswithaknown
inducer of ER stress, such as tunicamycin, are undertaken to
conﬁrm detection of a protein of the correct size (29 kDa) in
the nuclear fraction. Wethen adviseuseof apositivecontrol
for immunocytochemistry with the antibody that is suc-
cessful for Western blotting, ensuring that the mode of
ﬁxation mirrorsthat is tobe used inthe test tissue (frozen vs.
parafﬁn embedded). Finally, a new lot of CHOP antibody
106 Cell Biochem Biophys (2008) 51:105–107even with the same catalog numberthat was previouslyused
needs to be tested and compared with the results obtained
with a previous antibody lot. Given these ﬁndings, it is also
perhaps advisable for authors to afﬁrm that these steps have
beenundertakenwhenreportingERstress(oritsabsence)on
the basis of nuclear CHOP detection.
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Fig. 1 The speciﬁcity of the CHOP antibodies. (a) INS 832/13 cells
expressing GFP (G), r-IAPP (R), or h-IAPP (H) were treated with
0.5 lg/ml tunicamycin and fractionated into cytoplasmic and nuclear
fractions. (b) INS cells were cultured in the presence or absence of 1
or 5 lg/ml tunicamycin (TM) for 6 h and fractionated. Lysates were
analyzed by immunoblotting using different CHOP antibodies.
Positive staining was also obtained using CHOP antibody 9C8
(cat#ab11419, Abcam). Non-speciﬁc signal in our testing conditions
in INS cells was obtained using CHOP antibodies cat#G6916
(lot#57K4864, Sigma) and cat#sc-793R-20 (lot# F0105, Santa Cruz).
The ﬁlters were also probed for PARP and GAPDH to show
successful fractionation to nuclear and cytoplasmic fractions, respec-
tively. (c) Human IAPP expressing INS cells (upper panel) and
pancreatic sections of human IAPP transgenic mouse (lower panel)
were stained with different CHOP antibodies. Positive staining was
also obtained using CHOP antibody 9C8 (cat#ab11419, Abcam)
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